|
|
A YAP/TAZ-CD54 axis is required for CXCR2−CD44− tumor-specific neutrophils to suppress gastric cancer |
Pingping Nie1,2, Weihong Zhang3,4, Yan Meng5, Moubin Lin6, Fenghua Guo7, Hui Zhang2, Zhenzhu Tong1,2, Meng Wang2, Fan Chen1,2, Liwei An3, Yang Tang3, Yi Han3, Ruixian Yu2, Wenjia Wang2, Yuanzhi Xu8, Linxin Wei5( ), Zhaocai Zhou2,9( ), Shi Jiao2( ) |
1. CAS Center for Excellence in Molecular Cell Science, Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Shanghai 200031, China 2. State Key Laboratory of Genetic Engineering, School of Life Sciences, Zhongshan Hospital, Fudan University, Shanghai 200438, China 3. Tongji University Cancer Center, Department of Medical Ultrasound, Shanghai Tenth People’s Hospital, Ultrasound Research and Education Institute, Tongji University School of Medicine, Shanghai 200072, China 4. Postdoctoral Station of Clinical Medicine, Shanghai Tenth People’s Hospital, Tongji University School of Medicine, Shanghai 200072, China 5. Tumor Immunology and Gene Therapy Center, Shanghai Eastern Hepatobiliary Surgery Hospital, Shanghai 200438, China 6. Department of General Surgery, Yangpu Hospital, Tongji University School of Medicine, Shanghai 200090, China 7. Department of General Surgery, Hua’shan Hospital, Fudan University Shanghai Medical College, Shanghai 200040, China 8. Department of Stomatology, Shanghai Tenth People’s Hospital, Tongji University School of Medicine, Shanghai 200072, China 9. Collaborative Innovation Center for Cancer Personalized Medicine, School of Public Health, Nanjing Medical University, Nanjing 211166, China |
|
|
Abstract As an important part of tumor microenvironment, neutrophils are poorly understood due to their spatiotemporal heterogeneity in tumorigenesis. Here we defined, at single-cell resolution, CD44−CXCR2− neutrophils as tumor-specific neutrophils (tsNeus) in both mouse and human gastric cancer (GC). We uncovered a Hippo regulon in neutrophils with unique YAP signature genes (e.g., ICAM1, CD14, EGR1) distinct from those identified in epithelial and/or cancer cells. Importantly, knockout of YAP/TAZ in neutrophils impaired their differentiation into CD54+ tsNeus and reduced their antitumor activity, leading to accelerated GC progression. Moreover, the relative amounts of CD54+ tsNeus were found to be negatively associated with GC progression and positively associated with patient survival. Interestingly, GC patients receiving neoadjuvant chemotherapy had increased numbers of CD54+ tsNeus. Furthermore, pharmacologically enhancing YAP activity selectively activated neutrophils to suppress refractory GC, with no significant inflammation-related side effects. Thus, our work characterized tumor-specific neutrophils in GC and revealed an essential role of YAP/TAZ-CD54 axis in tsNeus, opening a new possibility to develop neutrophil-based antitumor therapeutics.
|
Keywords
neutrophils
YAP
TAZ
gastric cancer
|
Corresponding Author(s):
Linxin Wei,Zhaocai Zhou,Shi Jiao
|
Issue Date: 18 July 2023
|
|
1 |
S Aibar, CB Gonzalez-Blas, T Moerman et al. SCENIC: single-cell regulatory network inference and clustering. Nat Methods 2017;14:1083–1086.
https://doi.org/10.1038/nmeth.4463
|
2 |
J Albrengues, MA Shields, D Ng et al. Neutrophil extracellular traps produced during inflammation awaken dormant cancer cells in mice. Science 2018;361:eaao4227.
https://doi.org/10.1126/science.aao4227
|
3 |
I Ballesteros, A Rubio-Ponce, M Genua et al. Co-option of neutrophil fates by tissue environments. Cell 2020.
|
4 |
T Beinert, S Münzing, K Possinger et al. Increased expression of the tetraspanins CD53 and CD63 on apoptotic human neutrophils. J Leukoc Biol 2000;67:369–373.
https://doi.org/10.1002/jlb.67.3.369
|
5 |
A Blaisdell, A Crequer, D Columbus et al. Neutrophils oppose uterine epithelial carcinogenesis via debridement of hypoxic tumor cells. Cancer Cell 2015;28:785–799.
https://doi.org/10.1016/j.ccell.2015.11.005
|
6 |
N. Borregaard Neutrophils, from marrow to microbes. Immunity 2010;33:657–670.
https://doi.org/10.1016/j.immuni.2010.11.011
|
7 |
OE Borregaard, N, Sorensen, K. Theilgaard-Monch Neutrophil granules: a library of innate immunity proteins. Trends Immunol 2007;28:340–345.
https://doi.org/10.1016/j.it.2007.06.002
|
8 |
J Cools-Lartigue, J Spicer, B McDonald et al. Neutrophil extracellular traps sequester circulating tumor cells and promote metastasis. J Clin Invest 2013;123:3446–3458.
https://doi.org/10.1172/JCI67484
|
9 |
JB Cowland, N. Borregaard Granulopoiesis and granules of human neutrophils. Immunol Rev 2016;273:11–28.
https://doi.org/10.1111/imr.12440
|
10 |
C Cui, K Chakraborty, XA Tang et al. Neutrophil elastase selectively kills cancer cells and attenuates tumorigenesis. Cell 2021;184:3163–3177.
https://doi.org/10.1016/j.cell.2021.04.016
|
11 |
HQ Dinh, T Eggert, MA Meyer et al. Coexpression of CD71 and CD117 identifies an early unipotent neutrophil progenitor population in human bone marrow. Immunity 2020; 53:319–334.
https://doi.org/10.1016/j.immuni.2020.07.017
|
12 |
KJ Eash, AM Greenbaum, PK Gopalan et al. CXCR2 and CXCR4 antagonistically regulate neutrophil trafficking from murine bone marrow. J Clin Invest 2010;120:2423–2431.
https://doi.org/10.1172/JCI41649
|
13 |
ER Elliott, JA Van Ziffle, P Scapini et al. Deletion of Syk in neutrophils prevents immune complex arthritis. J Immunol 2011;187:4319–4330.
https://doi.org/10.4049/jimmunol.1100341
|
14 |
EB Eruslanov, PS Bhojnagarwala, JG Quatromoni et al. Tumor-associated neutrophils stimulate T cell responses in early-stage human lung cancer. J Clin Invest 2014;124:5466–5480.
https://doi.org/10.1172/JCI77053
|
15 |
M Evrard, IWH Kwok, SZ Chong et al. Developmental analysis of bone marrow neutrophils reveals populations specialized in expansion, trafficking, and effector functions. Immunity 2018a;48;364–379.
https://doi.org/10.1016/j.immuni.2018.02.002
|
16 |
M Evrard, IWH Kwok, SZ Chong et al. Developmental analysis of bone marrow neutrophils reveals populations specialized in expansion, trafficking, and effector functions. Immunity 2018b;48:364–379.
https://doi.org/10.1016/j.immuni.2018.02.002
|
17 |
F Fan, Z He, LL Kong et al. Pharmacological targeting of kinases MST1 and MST2 augments tissue repair and regeneration. Sci Transl Med 2016;8:352ra108.
https://doi.org/10.1126/scitranslmed.aaf2304
|
18 |
V Finisguerra, G Di Conza, M Di Matteo et al. MET is required for the recruitment of anti-tumoural neutrophils. Nature 2015;522:349–353.
https://doi.org/10.1038/nature14407
|
19 |
J Geng, S Yu, H Zhao et al. The transcriptional coactivator TAZ regulates reciprocal differentiation of TH17 cells and Treg cells. Nat Immunol 2017;18:800–812.
https://doi.org/10.1038/ni.3748
|
20 |
M Gershkovitz, Y Caspi, T Fainsod-Levi et al. TRPM2 Mediates Neutrophil Killing of Disseminated Tumor Cells. Cancer Res 2018;78:2680–2690.
https://doi.org/10.1158/0008-5472.CAN-17-3614
|
21 |
Z Granot, E Henke, EA Comen et al. Tumor entrained neutrophils inhibit seeding in the premetastatic lung. Cancer Cell 2011;20:300–314.
https://doi.org/10.1016/j.ccr.2011.08.012
|
22 |
KF Harvey, X Zhang, DM. Thomas The Hippo pathway and human cancer. Nat Rev Cancer 2013;13:246–257.
https://doi.org/10.1038/nrc3458
|
23 |
H Hock, MJ Hamblen, HM Rooke et al. Intrinsic requirement for zinc finger transcription factor Gfi-1 in neutrophil differentiation. Immunity 2003;18:109–120.
https://doi.org/10.1016/S1074-7613(02)00501-0
|
24 |
B Huang, PY Pan, Q Li et al. Gr-1+CD115+ immature myeloid suppressor cells mediate the development of tumor-induced T regulatory cells and T-cell anergy in tumor-bearing host. Cancer Res 2006;66:1123–1131.
https://doi.org/10.1158/0008-5472.CAN-05-1299
|
25 |
S Jaillon, A Ponzetta, D Di Mitri et al. Neutrophil diversity and plasticity in tumour progression and therapy. Nat Rev Cancer 2020;20:485–503.
https://doi.org/10.1038/s41568-020-0281-y
|
26 |
S Jiao, H Wang, Z Shi et al. A peptide mimicking VGLL4 function acts as a YAP antagonist therapy against gastric cancer. Cancer Cell 2014;25:166–180.
https://doi.org/10.1016/j.ccr.2014.01.010
|
27 |
S Jiao, Z Zhang, C Li et al. The kinase MST4 limits inflammatory responses through direct phosphorylation of the adaptor TRAF6. Nat Immunol 2015;16:246–257.
https://doi.org/10.1038/ni.3097
|
28 |
E Kolaczkowska, P. Kubes Neutrophil recruitment and function in health and inflammation. Nat Rev Immunol 2013;13:159–175.
https://doi.org/10.1038/nri3399
|
29 |
I Kwok, E Becht, Y Xia et al. Combinatorial single-cell analyses of granulocyte- monocyte progenitor heterogeneity reveals an early uni-potent neutrophil progenitor. Immunity 2020;53:303–318.
https://doi.org/10.1016/j.immuni.2020.06.005
|
30 |
PX Liew, P. Kubes The neutrophil’s role during health and disease. Physiol Rev 2019;99:1223–1248.
https://doi.org/10.1152/physrev.00012.2018
|
31 |
B McDonald, EF McAvoy, F Lam et al. Interaction of CD44 and hyaluronan is the dominant mechanism for neutrophil sequestration in inflamed liver sinusoids. J Exp Med 2008;205:915–927.
https://doi.org/10.1084/jem.20071765
|
32 |
S Mensurado, M Rei, T Lança et al. Tumor-associated neutrophils suppress pro-tumoral IL-17+ γδ T cells through induction of oxidative stress. PLoS Biol 2018;16:e2004990.
https://doi.org/10.1371/journal.pbio.2004990
|
33 |
S Metkar, KS Kim, J Silver et al. Differential expression of CD14-dependent and independent pathways for chemokine induction regulates neutrophil trafficking in infection. J Leukoc Biol 2012;92:389–396.
https://doi.org/10.1189/jlb.0112011
|
34 |
T Németh, M Sperandio, A. Mócsai Neutrophils as emerging therapeutic targets. Nat Rev Drug Discovery 2020;19:253–275.
https://doi.org/10.1038/s41573-019-0054-z
|
35 |
LG Ng, R Ostuni, A. Hidalgo Heterogeneity of neutrophils. Nat Rev Immunol 2019;19:255–265.
https://doi.org/10.1038/s41577-019-0141-8
|
36 |
X Ni, J Tao, J Barbi et al. YAP is essential for treg-mediated suppression of antitumor immunity. Cancer Discov 2018;8:1026–1043.
https://doi.org/10.1158/2159-8290.CD-17-1124
|
37 |
H Nozawa, C Chiu, D. Hanahan Infiltrating neutrophils mediate the initial angiogenic switch in a mouse model of multistage carcinogenesis. Proc Natl Acad Sci USA 2006;103:12493.
https://doi.org/10.1073/pnas.0601807103
|
38 |
S Ostrand-Rosenberg, P. Sinha Myeloid-derived suppressor cells: linking inflammation and cancer. J Immunol 2009;182:4499–4506.
https://doi.org/10.4049/jimmunol.0802740
|
39 |
D. Pan The hippo signaling pathway in development and cancer. Dev Cell 2010;19:491–505.
https://doi.org/10.1016/j.devcel.2010.09.011
|
40 |
A Ponzetta, R Carriero, S Carnevale et al. Neutrophils driving unconventional t cells mediate resistance against murine sarcomas and selected human tumors. Cell 2019;178:346–360.
https://doi.org/10.1016/j.cell.2019.05.047
|
41 |
X Qiu, Q Mao, Y Tang et al. Reversed graph embedding resolves complex single-cell trajectories. Nat Methods 2017;14:979–982.
https://doi.org/10.1038/nmeth.4402
|
42 |
X Ren, G Zhong, Q Zhang et al. Reconstruction of cell spatial organization from single-cell RNA sequencing data based on ligand-receptor mediated self-assembly. Cell Res 2020;30:763–778.
https://doi.org/10.1038/s41422-020-0353-2
|
43 |
ME Shaul, ZG. Fridlender Tumour-associated neutrophils in patients with cancer. Nat Rev Clin Oncol 2019;16:601–620.
https://doi.org/10.1038/s41571-019-0222-4
|
44 |
F Shojaei, M Singh, JD Thompson et al. Role of Bv8 in neutrophil-dependent angiogenesis in a transgenic model of cancer progression. Proc Natl Acad Sci USA 2008;105:2640–2645.
https://doi.org/10.1073/pnas.0712185105
|
45 |
S Singhal, PS Bhojnagarwala, S O’Brien et al. Origin and role of a subset of tumor-associated neutrophils with antigen-presenting cell features in early-stage human lung cancer. Cancer Cell 2016;30:120–135.
https://doi.org/10.1016/j.ccell.2016.06.001
|
46 |
A Spiegel, MW Brooks, S Houshyar et al. Neutrophils suppress intraluminal NK cell-mediated tumor cell clearance and enhance extravasation of disseminated carcinoma cells. Cancer Discov 2016;6:630–649.
https://doi.org/10.1158/2159-8290.CD-15-1157
|
47 |
BM Szczerba, F Castro-Giner, M Vetter et al. Neutrophils escort circulating tumour cells to enable cell cycle progression. Nature 2019;566:553–557.
https://doi.org/10.1038/s41586-019-0915-y
|
48 |
Y Tang, G Fang, F Guo et al. Selective inhibition of STRN3-containing PP2A phosphatase restores Hippo tumor-suppressor activity in gastric cancer. Cancer Cell 2020;38:115–128.
https://doi.org/10.1016/j.ccell.2020.05.019
|
49 |
L van der Maaten, G. Hinton Visualizing data using t-SNE. J Mach Learn Res 2008;9:2579–2605.
|
50 |
F Veglia, A Hashimoto, H Dweep et al. Analysis of classical neutrophils and polymorphonuclear myeloid-derived suppressor cells in cancer patients and tumor-bearing mice. J Exp Med 2021;218.
https://doi.org/10.1084/jem.20201803
|
51 |
TT Wang, YL Zhao, LS Peng et al. Tumour-activated neutrophils in gastric cancer foster immune suppression and disease progression through GM-CSF-PD-L1 pathway. Gut 2017;66:1900–1911.
https://doi.org/10.1136/gutjnl-2016-313075
|
52 |
X Xie, Q Shi, P Wu et al. Single-cell transcriptome profiling reveals neutrophil heterogeneity in homeostasis and infection. Nat Immunol 2020a;21:1119–1133.
https://doi.org/10.1038/s41590-020-0736-z
|
53 |
X Xie, Q Shi, P Wu et al. Single-cell transcriptome profiling reveals neutrophil heterogeneity in homeostasis and infection. Nat Immunol 2020b;21:1119–1133.
https://doi.org/10.1038/s41590-020-0736-z
|
54 |
R Yamanaka, C Barlow, J Lekstrom-Himes et al. Impaired granulopoiesis, myelodysplasia, and early lethality in CCAAT/enhancer binding protein epsilon-deficient mice. Proc Natl Acad Sci USA 1997;94:13187–13192.
https://doi.org/10.1073/pnas.94.24.13187
|
55 |
L Yang, Q Liu, X Zhang et al. DNA of neutrophil extracellular traps promotes cancer metastasis via CCDC25. Nature 2020;583:133–138.
https://doi.org/10.1038/s41586-020-2394-6
|
56 |
JI Youn, M Collazo, IN Shalova et al. Characterization of the nature of granulocytic myeloid-derived suppressor cells in tumor-bearing mice. J Leukoc Biol 2012;91:167–181.
https://doi.org/10.1189/jlb.0311177
|
57 |
FX Yu, Z Meng, SW Plouffe et al. Hippo pathway regulation of gastro-intestinal tissues. Annu Rev Physiol 2015;77:201–227.
https://doi.org/10.1146/annurev-physiol-021014-071733
|
58 |
F Zanconato, M Forcato, G Battilana et al. Genome-wide association between YAP/TAZ/TEAD and AP-1 at enhancers drives oncogenic growth. Nat Cell Biol 2015;17:1218–1227.
https://doi.org/10.1038/ncb3216
|
59 |
H Zhang, CY Liu, ZY Zha et al. TEAD transcription factors mediate the function of TAZ in cell growth and epithelial-mesenchymal transition. J Biol Chem 2009;284:13355–13362.
https://doi.org/10.1074/jbc.M900843200
|
60 |
B Zhao, K Tumaneng, KL. Guan The Hippo pathway in organ size control, tissue regeneration and stem cell self-renewal. Nat Cell Biol 2011;13:877–883.
https://doi.org/10.1038/ncb2303
|
61 |
B Zhao, X Ye, J Yu et al. TEAD mediates YAP-dependent gene induction and growth control. Genes Dev 2008;22:1962–1971.
https://doi.org/10.1101/gad.1664408
|
62 |
YP Zhu, L Padgett, HQ Dinh et al. Identification of an early unipotent neutrophil progenitor with pro-tumoral activity in mouse and human bone marrow. Cell Rep 2018;24:2329–2341.
https://doi.org/10.1016/j.celrep.2018.07.097
|
63 |
R Zilionis, C Engblom, C Pfirschke et al. Single-cell transcriptomics of human and mouse lung cancers reveals conserved myeloid populations across individuals and species. Immunity 2019;50:1317–1334.
https://doi.org/10.1016/j.immuni.2019.03.009
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|